Search research articles
Contact Us
Filters
Showing results (81-90 of 122) with videos related to
Page
of 13
Sort By:
Blood
|
March 21, 2009
Induction of angiogenesis by normal and malignant plasma cells
Dirk Hose, Jérôme Moreaux, Tobias Meissner, et al.
Cancer Research Communications
|
April 10, 2024
Modeling Myeloma Dissemination In Vitro with hMSC-interacting Subpopulations of INA-6 Cells and Their Aggregation/Detachment Dynamics
Martin Kuric, Susanne Beck, Doris Schneider, et al.
Haematologica
|
October 2, 2010
Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma
Dirk Hose, Thierry Rème, Thomas Hielscher, et al.
Frontiers in Immunology
|
December 26, 2022
The BLM helicase is a new therapeutic target in multiple myeloma involved in replication stress survival and drug resistance
Sara Ovejero, Elena Viziteu, Laure Dutrieux, et al.
Blood Advances
|
October 18, 2018
Cytogenetic intraclonal heterogeneity of plasma cell dyscrasia in AL amyloidosis as compared with multiple myeloma
Tilmann Bochtler, Maximilian Merz, Thomas Hielscher, et al.
Blood
|
February 21, 2009
The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor
Anne Catherine Sprynski, Dirk Hose, Laurent Caillot, et al.
Haematologica
|
May 13, 2017
Longitudinal fluorescence <i>in situ</i> hybridization reveals cytogenetic evolution in myeloma relapsing after autologous transplantation
Maximilian Merz, Anna Jauch, Thomas Hielscher, et al.
British Journal of Haematology
|
March 13, 2020
Identification of patients with smouldering multiple myeloma at ultra-high risk of progression using serum parameters: the Czech Myeloma Group model
Roman Hájek, Viera Sandecka, Ivan Špička, et al.
British Journal of Cancer
|
March 4, 2018
DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells
Angelique Bruyer, Ken Maes, Laurie Herviou, et al.
Leukemia
|
October 11, 2023
High-throughput electron tomography identifies centriole over-elongation as an early event in plasma cell disorders
Sebastian Köhrer, Tobias Dittrich, Martin Schorb, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 122) with videos related to
Sort By:
Page
of 13
Blood
|
March 21, 2009
Induction of angiogenesis by normal and malignant plasma cells
Dirk Hose, Jérôme Moreaux, Tobias Meissner, et al.
Cancer Research Communications
|
April 10, 2024
Modeling Myeloma Dissemination In Vitro with hMSC-interacting Subpopulations of INA-6 Cells and Their Aggregation/Detachment Dynamics
Martin Kuric, Susanne Beck, Doris Schneider, et al.
Haematologica
|
October 2, 2010
Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma
Dirk Hose, Thierry Rème, Thomas Hielscher, et al.
Frontiers in Immunology
|
December 26, 2022
The BLM helicase is a new therapeutic target in multiple myeloma involved in replication stress survival and drug resistance
Sara Ovejero, Elena Viziteu, Laure Dutrieux, et al.
Blood Advances
|
October 18, 2018
Cytogenetic intraclonal heterogeneity of plasma cell dyscrasia in AL amyloidosis as compared with multiple myeloma
Tilmann Bochtler, Maximilian Merz, Thomas Hielscher, et al.
Blood
|
February 21, 2009
The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor
Anne Catherine Sprynski, Dirk Hose, Laurent Caillot, et al.
Haematologica
|
May 13, 2017
Longitudinal fluorescence <i>in situ</i> hybridization reveals cytogenetic evolution in myeloma relapsing after autologous transplantation
Maximilian Merz, Anna Jauch, Thomas Hielscher, et al.
British Journal of Haematology
|
March 13, 2020
Identification of patients with smouldering multiple myeloma at ultra-high risk of progression using serum parameters: the Czech Myeloma Group model
Roman Hájek, Viera Sandecka, Ivan Špička, et al.
British Journal of Cancer
|
March 4, 2018
DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells
Angelique Bruyer, Ken Maes, Laurie Herviou, et al.
Leukemia
|
October 11, 2023
High-throughput electron tomography identifies centriole over-elongation as an early event in plasma cell disorders
Sebastian Köhrer, Tobias Dittrich, Martin Schorb, et al.
Page
of 13